We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CLRPF market cap is 1.18B. The company's latest EPS is AUD -0.1362 and P/E is -42.80.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 0 | 3.29M | 6.46M | 9.8M | 11.51M |
| Operating Income | 0 | -10.22M | -23.83M | -26.36M | -44.8M |
| Net Income | 0 | -10.22M | -23.76M | -24.6M | -42.32M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 113.48M | 22.61M | 99.82M | 76.9M | 154.63M |
| Total Liabilities | 2.02M | 2.34M | 7.59M | 7.72M | 8.33M |
| Total Equity | 111.46M | 20.28M | 92.24M | 69.18M | 146.3M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | N/A | -7.68M | -13.31M | -27.5M | -43.24M |
| Investing | N/A | -60k | -26.71M | 3.15M | -55.31M |
| Financing | N/A | 10.92M | 86.93M | 232k | 115.21M |
| Market Cap | 1.18B |
| Price to Earnings Ratio | -42.80 |
| Price to Sales Ratio | 157.57 |
| Price to Cash Ratio | 37.83 |
| Price to Book Ratio | 12.38 |
| Dividend Yield | - |
| Shares Outstanding | 310.78M |
| Average Volume (1 week) | 7.82k |
| Average Volume (1 Month) | 8.81k |
| 52 Week Change | 275.25% |
| 52 Week High | 6.398 |
| 52 Week Low | 0.93825 |
| Spread (Intraday) | 0.42 (10.1%) |
| Company Name | Clarity Pharmaceuticals Ltd (PK) |
| Address |
national innovation centre, suite 212a, 2-4 cornwallis stre bathurst, new south wales |
| Website | https:// |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
